A new study led by Dr. Eugenia Oviedo-Joekes is continuing research into the use of injectable opioid agonist treatment as a way to help address the overdose crisis.

The “PORTIA” study follows up on earlier research that showed injectable opioids like diacetylmorphine, the active ingredient in heroin, and hydromorphone, the licensed pain medication commonly known as Dilaudid, are effective at attracting and retaining people in treatment who haven’t had success with methadone.

This latest study is investigating how injectable treatment can be scaled-up into effective and affordable services.